Floatz logo

PERPHENAZINE

Bipolar Disorder

University of New MexicoSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
73/ 100

Competitive context

67 Active assets in the Bipolar Disorder cohort.

Asset / SponsorPhaseRating
Asenapine
Dr. Stavroula Rakitzi
Phase 4BBB
Cipralex
First Affiliated Hospital of Zhejiang University
Phase 4BBB
CITALOPRAM
University of Texas Southwestern Medical Center
Phase 4BBB
LITHIUM, ELEMENTAL
University of Aarhus
Phase 4BBB
LAMOTRIGINE
Johns Hopkins University
Phase 4BBB

View all 50 →

Same molecule, other indications

PERPHENAZINE is also rated in:

psychotic disorderDormant
BB
Indicative ·
70 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →